Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Dose selection in the research literature varies with the application: musculoskeletal-injury studies commonly report 200250 g twice daily near the affected site, while gastrointestinal-focused protocols use 250500 g once or twice daily, subcutaneously
A researcher choosing between them is choosing between two fundamentally different pharmacological strategies for addressing the same condition
none of the compounds have been studied for continuous use
The amount of hype to evidence is just so skewed, its crazy, Dr Flynn McGuire, who studied the research, told Stat and Undark in 2025
We used 15 N-labeled FOXO4 FHD and p53 TAD with S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate (MTSL)-labeled Cys46 for the PRE experiments
Those with cancer history, pregnancy, or serious medical conditions should consult healthcare providers before use
US$ 23.58
US$ 25.93
US$ 23.25
US$ 24.88
US$ 28.39
US$ 21.88
US$ 23.95
US$ 25.78
US$ 28.60
US$ 28.76
US$ 28.18
US$ 20.31
US$ 27.11
US$ 28.99
